SUMMARY Studies of gastrin metabolism were performed in four dogs before and after nephrectomy. Synthetic human gastrin I was infused for two hours and serum samples were obtained at various times during and after infusion. Serum concentrations of gastrin were measured by radioimmunoassay. A two-compartment model was employed to calculate half-lives under each of four experimental conditions, low and high infusion rates, used both before and after nephrectomy. The model half-life was greatly prolonged after nephrectomy at both infusion rates (from 2.54 min to 5.15 min at the low rate, and from 2.85 min to 7.88 min at the high rate). The metabolic clearance rate, an expression of the rate of catabolism during infusion, decreased significantly after nephrectomy at both infusion rates. These observations indicate that the kidney is an important organ for the catabolism of exogenous gastrin.
Effect ofnephrectomy on the rate andpattern ofthe disappearance ofexogenous gastrin in dogs and were again subjected to the same protocol of infusions of gastrin in random order as described above. The data subjected to analysis were all obtained in the first 15 minutes after stopping the infusion, since near basal concentrations of gastrin had been achieved by that time in the studies that were done before nephrectomy.
Gastrin concentrations were measured by radioimmunoassay in which a double-antibody technique was used (Charters, Odell, Davidson, and Thompson, 1969; Jackson, Reeder, and Thompson, 1972) . The antigastrin antibody was developed in New Zealand white rabbits to synthetic human gastrin I (residues 2-17) conjugated to bovine serum albumin. All samples were assayed in duplicate; reproducibility was within ± 10%. The average of the duplicates was used as the serum concentration for each of the measurements. The lower limit of sensitivity of the assays in this study was 40 picograms (pg) per millilitre of serum. If no gastrin was detected, the value of 40 pg/ml was recorded for purposes of calculation.
To permit analysis of the disappearance of the exogenous gastrin, the basal level, representing endogenous gastrin, was subtracted from each postinfusion concentration. All data used for analysis reflect the subtraction of basal gastrin levels.
The concentrations of gastrin in pg/ml (observed minus basal) were plotted against time in each of the four experiments. The resulting curves on semilogarithmic paper were nonlinear. The results of Reeder and associates (1972b) The results were analysed initially by standard linear regression analysis (Steel and Torrie, 1960) . The nonlinear program, NONLIN, developed by Metzler (1970) was used to obtain final estimates of k1, k2, and k3, and from them revised estimates were calculated for the slopes of the first and second components of the disappearance curve, as described by Reeder and associates (1972b (Silvers, Swenson, Farquhar, and Reaven, 1969) , and the later component probably represents catabolism of the hormone. The analytical method which has been used is only suitable when mixing is rapid relative to metabolism (Stern, Farquhar, Silvers, and Reaven, 1968 The results of both studies are in general agreement with those of previous investigators (Blair, Farra, Richardson, and Steinbok, 1970; Ganguli, Elder, Smith, and Hunter, 1970; Ganguli, Cullen, and Irvine, 1971; McGuigan, Isaza, and Landor, 1971; Newton and Jaffe, 1971; Yalow and Berson, 1970a) but are not directly comparable because ofdifferences in methodology.
The kidney is known to be active in the degradation of several peptide hormones (Lauson, 1967; Narahara and Williams, 1957; Richards and Sayers, 1951; Salmon, Utiger, Parker, and Reichlin, 1962; Sonenberg and Money, 1955) . Early unpublished studies in our laboratory with injections of radioiodinated gastrin showed the renal cortex to take up activity to a greater degree than many other organs that were measured. This finding has been confirmed by Newton and Jaffe (1971) . Clendinnen and associates (1971) showed that the dog kidney inactivated 40 % of exogenous synthetic human gastrin presented to it, and recent studies by Hjelmquist, Reeder, Brandt, and The half-life of the second or 'catabolic' component of the disappearance curve in intact dogs is 11.05 minutes at the low dose and 9-17 at the high dose. Nephrectomy results in a profound increase in these half-lives in the individual dogs (with one 467 exception at the low dose) and the change is much more pronounced with the high dosage. The variation among dogs is quite large. The probable significance of this prolongation is that once distribution and mixing are accounted for, the rate of actual breakdown of gastrin in the absence of the kidneys is greatly slowed and may be exceeded by the rate of infusion of gastrin used in these experiments. The 'model' half-life is changed little, however, owing to masking of impaired catabolism (apparently by the distributional and mixing phases).
Calculation of the metabolic clearance rates from the data of constant infusion studies is independent of the number of compartments necessary to describe the system (Tait and Burstein, 1964) . We have calculated the MCR, therefore, as an estimate of rate of catabolism during the period of constant infusion. In these studies the metabolic clearance rate was significantly decreased following nephrectomy at both dose levels of infusion. This decrease following nephrectomy is additional evidence that the kidney is an important organ for catabolism of gastrin.
Metabolic studies with other polypeptide hormones, such as insulin (Field, Webster, and Drapanas, 1968) , have shown that the rate of destruction may rise with increases in the concentrations in the blood. Consequently, measurements of the rate of metabolism of gastrin at different levels might be expected to yield different results. The half-lives for gastrin in intact dogs determined in this study at two dosages of exogenous gastrin, however, were in close agreement.
Gastrin used in these studies was the small or heptadecapeptide form of human gastrin prepared synthetically. Most of the circulating gastrin has been found to be in a larger form (Yalow and Berson, 1970b) in which the heptadecapeptide is bound covalently to a peptide which may protect it from inactivation. The rapid rates of disappearance we have measured may be valid only at high levels of exogenous gastrin. They may also be influenced by the species configuration (human) of the exogenous gastrin used in these experiments in dogs.
